{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:14:42Z","timestamp":1793657682480,"version":"4.5.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 306\/2"],"award-info":[{"award-number":["EXC 306\/2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK 1727\/2"],"award-info":[{"award-number":["GRK 1727\/2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK 1743\/2"],"award-info":[{"award-number":["GRK 1743\/2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KFO 303\/1"],"award-info":[{"award-number":["KFO 303\/1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0896-1","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T23:39:50Z","timestamp":1536017990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients"],"prefix":"10.1186","volume":"13","author":[{"given":"Hiroaki","family":"Iwata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Vorobyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Recke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Prost-Squarcioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norito","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1394-1737","authenticated-orcid":false,"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"896_CR1","first-page":"10","volume":"13","author":"GT Elliott","year":"1895","unstructured":"Elliott GT. Two cases of epidermolysis bullosa. J Cutan Genitourin Dis. 1895;13:10.","journal-title":"J Cutan Genitourin Dis"},{"key":"896_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/archderm.1971.04000130003001","volume":"103","author":"HHJ Roenigk","year":"1971","unstructured":"Roenigk HHJ, Ryan JG, Bergfeld WF. Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Arch Dermatol. 1971;103:1\u201310.","journal-title":"Arch Dermatol"},{"key":"896_CR3","first-page":"1143","volume":"108","author":"W Kushniruk","year":"1973","unstructured":"Kushniruk W. The immunopathology of epidermolysis bullosa acquisita. Can Med Assoc J. 1973;108:1143\u20136.","journal-title":"Can Med Assoc J"},{"key":"896_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1365-2133.1980.tb06550.x","volume":"102","author":"C Nieboer","year":"1980","unstructured":"Nieboer C, Boorsma DM, Woerdeman MJ, Kalsbeek GL. Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients. Br J Dermatol. 1980;102:383\u201392.","journal-title":"Br J Dermatol"},{"key":"896_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/1523-1747.ep12526124","volume":"76","author":"H Yaoita","year":"1981","unstructured":"Yaoita H, Briggaman RA, Lawley TJ, Provost TT, Katz SI. Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol. 1981;76:288\u201392.","journal-title":"J Invest Dermatol"},{"key":"896_CR6","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJM198404193101602","volume":"310","author":"DT Woodley","year":"1984","unstructured":"Woodley DT, Briggaman RA, O\u2019Keefe EJ, Inman AO, Queen LL, Gammon WR. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med. 1984;310:1007\u201313.","journal-title":"N Engl J Med"},{"key":"896_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI113373","volume":"81","author":"DT Woodley","year":"1988","unstructured":"Woodley DT, Burgeson RE, Lunstrum G, Bruckner-Tuderman L, Reese MJ, Briggaman RA. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest. 1988;81:683\u20137.","journal-title":"J Clin Invest"},{"key":"896_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clindermatol.2011.03.011","volume":"30","author":"R Gupta","year":"2012","unstructured":"Gupta R, Woodley DT, Chen M. Epidermolysis bullosa acquisita. Clin Dermatol. 2012;30:60\u20139.","journal-title":"Clin Dermatol"},{"key":"896_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.4089","volume":"228","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, Ishii N, Ohata C, Furumura M. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease. J Pathol. 2012;228:1\u20137.","journal-title":"J Pathol"},{"key":"896_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.molmed.2013.06.003","volume":"19","author":"RJ Ludwig","year":"2013","unstructured":"Ludwig RJ, Kalies K, K\u00f6hl J, Zillikens D, Schmidt E. Emerging treatments for pemphigoid diseases. Trends Mol Med. 2013;19:501\u201312.","journal-title":"Trends Mol Med"},{"key":"896_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","volume":"8","author":"RJ Ludwig","year":"2017","unstructured":"Ludwig RJ, Vanhoorelbeke K, Leypoldt F, et al. Mechanisms of autoantibody-induced pathology. Front Immunol. 2017;8:603.","journal-title":"Front Immunol"},{"key":"896_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.det.2011.03.017","volume":"29","author":"F Caux","year":"2011","unstructured":"Caux F. Diagnosis and clinical features of epidermolysis bullosa acquisita. Dermatol Clin. 2011;29:485\u201391. x","journal-title":"Dermatol Clin"},{"key":"896_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","volume":"381","author":"E Schmidt","year":"2013","unstructured":"Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381:320\u201332.","journal-title":"Lancet"},{"key":"896_CR14","doi-asserted-by":"publisher","unstructured":"Prost-Squarcioni C, Caux F, Schmidt E, et al. International bullous diseases group - consensus on diagnostic criteria for epidermolysis bullosa acquisita. Br J Dermatol. 2017. https:\/\/doi.org\/10.1111\/bjd.16138 .","DOI":"10.1111\/bjd.16138"},{"key":"896_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1365-2133.2004.06006.x","volume":"151","author":"RM Vodegel","year":"2004","unstructured":"Vodegel RM, Jonkman MF, Pas HH, de Jong MC. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol. 2004;151:112\u20138.","journal-title":"Br J Dermatol"},{"key":"896_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/archderm.1996.03890260053008","volume":"132","author":"MC De Jong","year":"1996","unstructured":"De Jong MC, Bruins S, Heeres K, et al. Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping. Arch Dermatol. 1996;132:151\u20137.","journal-title":"Arch Dermatol"},{"key":"896_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1365-2133.2011.10346.x","volume":"165","author":"JJ Buijsrogge","year":"2011","unstructured":"Buijsrogge JJ, Diercks GF, Pas HH, Jonkman MF. The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy. Br J Dermatol. 2011;165:92\u20138.","journal-title":"Br J Dermatol"},{"key":"896_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2340\/00015555-1065","volume":"91","author":"JH Kim","year":"2011","unstructured":"Kim JH, Kim YH, Kim SC. Epidermolysis Bullosa Acquisita: a retrospective clinical analysis of 30 cases. Acta Derm Venereol. 2011;91:307\u201312.","journal-title":"Acta Derm Venereol"},{"key":"896_CR19","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1056\/NEJMicm1204895","volume":"368","author":"C Lam","year":"2013","unstructured":"Lam C, Vleugels RA. Images in clinical medicine. Epidermolysis bullosa acquisita. N Engl J Med. 2013;368:e17.","journal-title":"N Engl J Med"},{"key":"896_CR20","doi-asserted-by":"publisher","unstructured":"Ludwig RJ. Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita. ISRN Dermatol. 2013;2013:812029. https:\/\/doi.org\/10.1155\/2013\/812029 . PMID: 23956869, PMCID: PMC3727188.","DOI":"10.1155\/2013\/812029"},{"key":"896_CR21","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1038\/jid.2011.231","volume":"131","author":"C Zumelzu","year":"2011","unstructured":"Zumelzu C, Le Roux-Villet C, Loiseau P, et al. Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita. J Invest Dermatol. 2011;131:2386\u201393.","journal-title":"J Invest Dermatol."},{"key":"896_CR22","first-page":"451","volume":"139","author":"RH Wetzels","year":"1991","unstructured":"Wetzels RH, Robben HC, Leigh IM, Schaafsma HE, Vooijs GP, Ramaekers FC. Distribution patterns of type VII collagen in normal and malignant human tissues. Am J Pathol. 1991;139:451\u20139.","journal-title":"Am J Pathol"},{"key":"896_CR23","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1046\/j.1523-1747.2002.01772.x","volume":"118","author":"M Chen","year":"2002","unstructured":"Chen M, O\u2019Toole EA, Sanghavi J, et al. The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn\u2019s disease have autoantibodies to type VII collagen. J Invest Dermatol. 2002;118:1059\u201364.","journal-title":"J Invest Dermatol"},{"key":"896_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/path.2857","volume":"224","author":"N Ishii","year":"2011","unstructured":"Ishii N, Recke A, Mihai S, et al. Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita. J Pathol. 2011;224:234\u201344.","journal-title":"J Pathol"},{"key":"896_CR25","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1001\/archderm.135.8.954","volume":"135","author":"MC Luke","year":"1999","unstructured":"Luke MC, Darling TN, Hsu R, et al. Mucosal morbidity in patients with epidermolysis bullosa acquisita. Arch Dermatol. 1999;135:954\u20139.","journal-title":"Arch Dermatol"},{"key":"896_CR26","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/bjd.15592","volume":"177","author":"O Zehou","year":"2017","unstructured":"Zehou O, Raynaud JJ, Le Roux-Villet C, et al. Oesophageal involvement in 26 consecutive patients with mucous membrane pemphigoid. Br J Dermatol. 2017;177:1074\u201385.","journal-title":"Br J Dermatol"},{"key":"896_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1365-2230.1985.tb00546.x","volume":"10","author":"M Shaw","year":"1985","unstructured":"Shaw M, McKee PH, Gaminara E, Pearson TC, Evans B, McGibbon DH. Epidermolysis bullosa acquisita associated with chronic lymphatic leukaemia. Clin Exp Dermatol. 1985;10:162\u20138.","journal-title":"Clin Exp Dermatol"},{"key":"896_CR28","first-page":"321","volume":"125","author":"A Etienne","year":"1998","unstructured":"Etienne A, Ruffieux P, Didierjean L, Saurat JH. Epidermolysis bullosa acquisita and metastatic cancer of the uterine cervix. Ann Dermatol Venereol. 1998;125:321\u20133.","journal-title":"Ann Dermatol Venereol"},{"key":"896_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/00000372-198708000-00006","volume":"9","author":"L Medenica-Mojsilovic","year":"1987","unstructured":"Medenica-Mojsilovic L, Fenske NA, Espinoza CG. Epidermolysis bullosa acquisita. Direct immunofluorescence and ultrastructural studies. Am J Dermatopathol. 1987;9:324\u201333.","journal-title":"Am J Dermatopathol"},{"key":"896_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000079608","volume":"209","author":"S Abecassis","year":"2004","unstructured":"Abecassis S, Joly P, Genereau T, et al. Superpotent topical steroid therapy for epidermolysis bullosa acquisita. Dermatology. 2004;209:164\u20136.","journal-title":"Dermatology"},{"key":"896_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1365-2133.1997.tb01119.x","volume":"137","author":"Y Endo","year":"1997","unstructured":"Endo Y, Tamura A, Ishikawa O, Miyachi Y, Hashimoto T. Psoriasis vulgaris coexistent with epidermolysis bullosa acquisita. Br J Dermatol. 1997;137:783\u20136.","journal-title":"Br J Dermatol"},{"key":"896_CR32","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0190-9622(84)80459-4","volume":"11","author":"WR Gammon","year":"1984","unstructured":"Gammon WR, Briggaman RA, Woodley DT, Heald PW, Wheeler CEJ. Epidermolysis bullosa acquisita--a pemphigoid-like disease. J Am Acad Dermatol. 1984;11:820\u201332.","journal-title":"J Am Acad Dermatol"},{"key":"896_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/00005792-199907000-00003","volume":"78","author":"S Aractingi","year":"1999","unstructured":"Aractingi S, Bachmeyer C, Prost C, Caux F, Flageul B, Fermand JP. Subepidermal autoimmune bullous skin diseases associated with B-cell lymphoproliferative disorders. Medicine (Baltimore). 1999;78:228\u201335.","journal-title":"Medicine (Baltimore)"},{"key":"896_CR34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2340\/0001555558241244","volume":"58","author":"JK Livden","year":"1978","unstructured":"Livden JK, Nilsen R, Thunold S, Schjonsby H. Epidermolysis bullosa acquisita and Crohn\u2019s disease. Acta Derm Venereol. 1978;58:241\u20134.","journal-title":"Acta Derm Venereol"},{"key":"896_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1177\/014107688808100821","volume":"81","author":"BR Hughes","year":"1988","unstructured":"Hughes BR, Horne J. Epidermolysis bullosa acquisita and total ulcerative colitis. J R Soc Med. 1988;81:473\u20135.","journal-title":"J R Soc Med"},{"key":"896_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jdermsci.2004.11.010","volume":"37","author":"GJ Oostingh","year":"2005","unstructured":"Oostingh GJ, Sitaru C, Zillikens D, Kromminga A, L\u00fchrs H. Subclass distribution of type VII collagen-specific autoantibodies in patients with inflammatory bowel disease. J Dermatol Sci. 2005;37:182\u20134.","journal-title":"J Dermatol Sci"},{"key":"896_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2172-13-16","volume":"13","author":"E Licarete","year":"2012","unstructured":"Licarete E, Ganz S, Recknagel M, et al. Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases. BMC Immunol. 2012;13:16.","journal-title":"BMC Immunol"},{"key":"896_CR38","first-page":"409","volume":"55","author":"F Sherry-Dottridge","year":"1962","unstructured":"Sherry-Dottridge F. Case for diagnosis: acquired epidermatolysis bullosa? Proc R Soc Med. 1962;55:409.","journal-title":"Proc R Soc Med"},{"key":"896_CR39","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1001\/jama.1983.03340130064034","volume":"250","author":"B Raab","year":"1983","unstructured":"Raab B, Fretzin DF, Bronson DM, Scott MJ, Roenigk HHJ, Medenica M. Epidermolysis bullosa acquisita and inflammatory bowel disease. JAMA. 1983;250:1746\u20138.","journal-title":"JAMA"},{"key":"896_CR40","first-page":"1657","volume":"91","author":"S Schattenkirchner","year":"1996","unstructured":"Schattenkirchner S, Lemann M, Prost C, et al. Localized epidermolysis bullosa acquisita of the esophagus in a patient with Crohn\u2019s disease. Am J Gastroenterol. 1996;91:1657\u20139.","journal-title":"Am J Gastroenterol"},{"key":"896_CR41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12016-007-0027-6","volume":"33","author":"DT Woodley","year":"2007","unstructured":"Woodley DT, Remington J, Chen M. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. Clin Rev Allergy Immunol. 2007;33:78\u201384.","journal-title":"Clin Rev Allergy Immunol"},{"key":"896_CR42","doi-asserted-by":"crossref","unstructured":"Prost-Squarcioni C, Caux F. Epidermolysis bullosa acquisita. In: Murrell D, editor. Blistering diseases- clinical features, pathogenesis, treatment. Heidelberg: Springer; 2015. p. 405\u201312.","DOI":"10.1007\/978-3-662-45698-9_40"},{"key":"896_CR43","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.annder.2011.01.019","volume":"138","author":"C Le Roux-Villet","year":"2011","unstructured":"Le Roux-Villet C, Prost-Squarcioni C. Epidermolysis bullosa acquisita: literature review. Ann Dermatol Venereol. 2011;138:228\u201346.","journal-title":"Ann Dermatol Venereol"},{"key":"896_CR44","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.jaad.2011.12.032","volume":"68","author":"L Komorowski","year":"2012","unstructured":"Komorowski L, Muller R, Vorobyev A, et al. Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. J Am Acad Dermatol. 2012;68:e89\u201395.","journal-title":"J Am Acad Dermatol"},{"key":"896_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1365-2230.2005.01989.x","volume":"31","author":"M Campos","year":"2006","unstructured":"Campos M, Silvente C, Lecona M, Su\u00e1rez R, L\u00e1zaro P. Epidermolysis bullosa acquisita: diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin. Clin Exp Dermatol. 2006;31:71\u20133.","journal-title":"Clin Exp Dermatol"},{"key":"896_CR46","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000246282","volume":"193","author":"CW Lee","year":"1996","unstructured":"Lee CW, Kim SC, Han H. Distribution of HLA class II alleles in Korean patients with epidermolysis bullosa acquisita. Dermatology. 1996;193:328\u20139.","journal-title":"Dermatology"},{"key":"896_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/1523-1747.ep12285634","volume":"108","author":"M Chen","year":"1997","unstructured":"Chen M, Chan LS, Cai X, O\u2019Toole EA, Sample JC, Woodley DT. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol. 1997;108:68\u201372.","journal-title":"J Invest Dermatol"},{"key":"896_CR48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3349\/ymj.1998.39.4.339","volume":"39","author":"HJ Cho","year":"1998","unstructured":"Cho HJ, Lee IJ, Kim SC. Complement-fixing abilities and IgG subclasses of autoantibodies in epidermolysis bullosa acquisita. Yonsei Med J. 1998;39:339\u201344.","journal-title":"Yonsei Med J"},{"key":"896_CR49","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/j.1468-3083.2011.04205.x","volume":"26","author":"AR Ahmed","year":"2012","unstructured":"Ahmed AR, Gurcan HM. Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up. J Eur Acad Dermatol Venereol. 2012;26:1074\u201383.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"896_CR50","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jaad.2016.01.005","volume":"74","author":"V Seta","year":"2016","unstructured":"Seta V, Aucouturier F, Bonnefoy J, et al. Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA). J Am Acad Dermatol. 2016;74:1166\u201372.","journal-title":"J Am Acad Dermatol"},{"key":"896_CR51","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1080\/1744666X.2016.1196136","volume":"12","author":"T Hashimoto","year":"2016","unstructured":"Hashimoto T, Jin Z, Ishii N. Clinical and immunological studies for 105 Japanese seropositive patients of epidermolysis bullosa acquisita examined at Kurume University. Expert Rev Clin Immunol. 2016;12:895\u2013902.","journal-title":"Expert Rev Clin Immunol"},{"key":"896_CR52","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1365-2133.1996.tb01511.x","volume":"135","author":"Y Kawachi","year":"1996","unstructured":"Kawachi Y, Ikegami M, Hashimoto T, Matsumura K, Tanaka T, Otsuka F. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant. Br J Dermatol. 1996;135:443\u20137.","journal-title":"Br J Dermatol"},{"key":"896_CR53","first-page":"623","volume":"77","author":"H Tanaka","year":"1997","unstructured":"Tanaka H, Ishida-Yamamoto A, Hashimoto T, et al. A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen. Lab Investig. 1997;77:623\u201332.","journal-title":"Lab Investig"},{"key":"896_CR54","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1365-2133.1997.18191915.x","volume":"137","author":"F Caux","year":"1997","unstructured":"Caux F, Kirtschig G, Lemarchand-Venencie F, et al. IgA-epidermolysis bullosa acquisita in a child resulting in blindness. Br J Dermatol. 1997;137:270\u20135.","journal-title":"Br J Dermatol"},{"key":"896_CR55","first-page":"2","volume":"14","author":"MH Noe","year":"2008","unstructured":"Noe MH, Chen M, Woodley DT, Fairley JA. Familial epidermolysis bullosa acquisita. Dermatol Online J. 2008;14:2.","journal-title":"Dermatol Online J"},{"key":"896_CR56","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1001\/archderm.1989.01670190078009","volume":"125","author":"CC McCuaig","year":"1989","unstructured":"McCuaig CC, Chan LS, Woodley DT, Rasmussen JE, Cooper KD. Epidermolysis bullosa acquisita in childhood. Differentiation from hereditary epidermolysis bullosa. Arch Dermatol. 1989;125:944\u20139.","journal-title":"Arch Dermatol"},{"key":"896_CR57","doi-asserted-by":"publisher","first-page":"717","DOI":"10.4103\/0378-6323.190846","volume":"82","author":"SV Pawar","year":"2016","unstructured":"Pawar SV, Mohite AR, Surude RG, Rathi PM, Nayak CS. Epidermolysis bullosa acquisita associated with dysphagia and stricture of esophagus. Indian J Dermatol Venereol Leprol. 2016;82:717\u20139.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"896_CR58","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/1346-8138.13546","volume":"44","author":"TM Yan","year":"2017","unstructured":"Yan TM, He CX, Hua BL, et al. Coexistence of acquired hemophilia a and epidermolysis bullosa acquisita: two case reports and published work review. J Dermatol. 2017;44:76\u20139.","journal-title":"J Dermatol"},{"key":"896_CR59","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/jid.2014.381","volume":"135","author":"A Tsuchisaka","year":"2015","unstructured":"Tsuchisaka A, Ohara K, Ishii N, Nguyen NT, Marinkovich MP, Hashimoto T. Type VII collagen is the major autoantigen for sublamina densa-type linear IgA bullous dermatosis. J Invest Dermatol. 2015;135:626\u20139.","journal-title":"J Invest Dermatol"},{"key":"896_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2007.05.002","volume":"29","author":"WW Eaton","year":"2007","unstructured":"Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007;29:1\u20139.","journal-title":"J Autoimmun"},{"key":"896_CR61","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/art.1780400909","volume":"40","author":"EM Tan","year":"1997","unstructured":"Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in \u201chealthy\u201d individuals. Arthritis Rheum. 1997;40:1601\u201311.","journal-title":"Arthritis Rheum"},{"key":"896_CR62","first-page":"267","volume":"12","author":"F Cacciapaglia","year":"2008","unstructured":"Cacciapaglia F, Arcarese L, Rigon A, et al. Antinuclear antibodies prevalence in Filipinos migrated to Italy. Eur Rev Med Pharmacol Sci. 2008;12:267\u201370.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"896_CR63","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/s10165-008-0028-1","volume":"18","author":"N Hayashi","year":"2008","unstructured":"Hayashi N, Koshiba M, Nishimura K, et al. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol. 2008;18:153\u201360.","journal-title":"Mod Rheumatol"},{"key":"896_CR64","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/art.34380","volume":"64","author":"M Satoh","year":"2012","unstructured":"Satoh M, Chan EK, Ho LA, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum. 2012;64:2319\u201327.","journal-title":"Arthritis Rheum"},{"key":"896_CR65","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/exd.12445","volume":"23","author":"J Pr\u00fcssmann","year":"2014","unstructured":"Pr\u00fcssmann J, Pr\u00fcssmann W, Recke A, et al. Co-occurrence of autoantibodies in healthy blood donors. Exp Dermatol. 2014;23:519\u201321.","journal-title":"Exp Dermatol"},{"key":"896_CR66","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3389\/fimmu.2017.01992","volume":"8","author":"T Sezin","year":"2017","unstructured":"Sezin T, Vorobyev A, Sadik CD, Zillikens D, Gupta Y, Ludwig RJ. Gene expression analysis reveals novel shared gene signatures and candidate molecular mechanisms between pemphigus and systemic lupus Erythematosus in CD4. Front Immunol. 2017;8:1992.","journal-title":"Front Immunol"},{"key":"896_CR67","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1067\/mjd.2001.113693","volume":"44","author":"L Engineer","year":"2001","unstructured":"Engineer L, Ahmed AR. Emerging treatment for epidermolysis bullosa acquisita. J Am Acad Dermatol. 2001;44:818\u201328.","journal-title":"J Am Acad Dermatol"},{"key":"896_CR68","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/exd.13415","volume":"26","author":"K Bieber","year":"2017","unstructured":"Bieber K, Koga H, Nishie W. In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases. Exp Dermatol. 2017;26:1163\u201370.","journal-title":"Exp Dermatol"},{"key":"896_CR69","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/jid.2014.453","volume":"135","author":"M Hirose","year":"2015","unstructured":"Hirose M, Tiburzy B, Ishii N, et al. Effects of intravenous immunoglobulins on mice with experimental epidermolysis bullosa acquisita. J Invest Dermatol. 2015;135:768\u201375.","journal-title":"J Invest Dermatol"},{"key":"896_CR70","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/JID.2015.356","volume":"136","author":"M Kasperkiewicz","year":"2016","unstructured":"Kasperkiewicz M, Sadik CD, Bieber K, et al. Epidermolysis bullosa acquisita: from pathophysiology to novel therapeutic options. J Invest Dermatol. 2016;136:24\u201333.","journal-title":"J Invest Dermatol"},{"key":"896_CR71","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/exd.13335","volume":"26","author":"RJ Ludwig","year":"2017","unstructured":"Ludwig RJ. Signaling and targeted-therapy of inflammatory cells in epidermolysis bullosa acquisita. Exp Dermatol. 2017;26:1179\u201386. PMID: 28266741","journal-title":"Exp Dermatol"},{"key":"896_CR72","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jdermsci.2011.03.003","volume":"62","author":"MA Saleh","year":"2011","unstructured":"Saleh MA, Ishii K, Kim YJ, et al. Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients. J Dermatol Sci. 2011;62:169\u201375.","journal-title":"J Dermatol Sci"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0896-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0896-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0896-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T17:06:23Z","timestamp":1693847183000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0896-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["896"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0896-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"8 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final version of the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RJL and DZ received honoraria and an unlimited research grant from Biotest. The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"153"}}